526
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis

, , &
Article: 2333784 | Received 21 Nov 2023, Accepted 17 Feb 2024, Published online: 11 Apr 2024

References

  • Al-Saraireh, Y. M., et al., 2021. Cytochrome 4Z1 expression is correlated with poor prognosis in patients with cervical cancer. Current Oncology (Toronto, Ont.), 28 (5), 1–9.
  • Bhargava, S., et al., 2017. Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma. Oncotarget, 8 (10), 16650–16668.
  • Bhatla, N., et al., 2021. Cancer of the cervix uteri: 2021 update. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 155 Suppl 1Suppl 1 (Suppl 1), 28–44.
  • Bitoun, E. and Davies, K. E., 2009. The robotic mouse: understanding the role of AF4, a cofactor of transcriptional elongation and chromatin remodelling, in purkinje cell function. Cerebellum (London, England), 8 (3), 175–183.
  • Chandra, S., et al., 2022. Molecular heterogeneity of cervical cancer among different ethnic/racial populations. Journal of Racial and Ethnic Health Disparities, 9 (6), 2441–2450.
  • Chandrashekar, D. S., et al., 2017. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, N.Y.), 19 (8), 649–658.
  • Chen, F., et al., 2020. RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer. Journal of Biomedical Research, 34 (2), 129–138.
  • Cohen, P. A., et al., 2019. Cervical cancer. Lancet (London, England), 393 (10167), 169–182.
  • Fan, A., et al., 2022. A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways. Frontiers in Oncology, 12, 950094.
  • Fang, Y., et al., 2022. AFF4 predicts the prognosis of colorectal cancer patients and suppresses colorectal cancer metastasis via promoting CDH1 expression. Frontiers in Oncology, 12, 797392.
  • Ferrall, L., et al., 2021. Cervical cancer immunotherapy: facts and hopes. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 27 (18), 4953–4973.
  • Gao, H., et al., 2022. Circular RNA hsa_circ_0057452 facilitates keloid progression by targeting the microRNA-1225-3p/AF4/FMR2 family member 4 axis. Bioengineered, 13 (5), 13815–13828.
  • Heidegger, H., et al., 2017. The prostaglandin EP3 receptor is an independent negative prognostic factor for cervical cancer patients. International Journal of Molecular Sciences, 18 (7), 1571.
  • Johnson, C. A., et al., 2019. Cervical cancer: an overview of pathophysiology and management. Seminars in Oncology Nursing, 35 (2), 166–174.
  • Koh, W. J., et al., 2015. Cervical cancer, version 2.2015. Journal of the National Comprehensive Cancer Network: JNCCN, 13 (4), 395–404; quiz 404.
  • Kong, K., et al., 2023. Integrative genomic profiling reveals characteristics of lymph node metastasis in small cell lung cancer. Translational Lung Cancer Research, 12 (2), 295–311.
  • Lefèvre, L., et al., 2015. Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of beta-catenin in adrenocortical carcinoma. Oncogenesis, 4 (7), e161–e161.
  • Liang, X., et al., 2022. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer. Molecular Biology Reports, 49 (5), 3939–3947.
  • Liao, W., et al., 2023. Diagnostic, prognostic, and immunological roles of CD177 in cervical cancer. Journal of Cancer Research and Clinical Oncology, 149 (1), 173–189.
  • Livak, K. J. and Schmittgen, T. D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.), 25 (4), 402–408.
  • Luan, S., et al., 2018. Interleukin 6 receptor (IL-6R) was an independent prognostic factor in cervical cancer. Histology and Histopathology., 33 (3), 269–276.
  • Marschalek, R., 2010. Mixed lineage leukemia: roles in human malignancies and potential therapy. The FEBS Journal, 277 (8), 1822–1831.
  • Merz, J., et al., 2020. Revised FIGO staging for cervical cancer - a new role for MRI. Rofo: Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, 192 (10), 937–944.
  • Poddar, P. and Maheshwari, A., 2021. Surgery for cervical cancer: consensus & controversies. The Indian Journal of Medical Research, 154 (2), 284–292.
  • Shi, Y., et al., 2018. AFF3 upregulation mediates tamoxifen resistance in breast cancers. Journal of Experimental & Clinical Cancer Research: Cr, 37 (1), 254.
  • Song, P., et al., 2023. The underlying mechanism involved in gefitinib resistance and corresponding experiment validation in lung cancer. Mediators of Inflammation, 2023, 9658912–9658927.
  • Tang, Z., et al., 2017. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research, 45 (W1), W98–W102.
  • Tirtakusuma, R., et al., 2022. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia. Blood, 140 (17), 1875–1890.
  • Tsuda, N., et al., 2016. Chemotherapy and molecular targeting therapy for recurrent cervical cancer. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu, 28 (2), 241–253.
  • von Bergh, A. R., et al., 2002. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia. Genes, Chromosomes & Cancer, 35 (1), 92–96.
  • Wang, D., et al., 2018. The role of MCM5 expression in cervical cancer: Correlation with progression and prognosis. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 98, 165–172.
  • Wang, R., et al., 2022. PD-L1: can it be a biomarker for the prognosis or a promising therapeutic target in cervical cancer? International Immunopharmacology, 103, 108484.
  • Yue, J., et al., 2021. Suppression of the NTS-CPS1 regulatory axis by AFF1 in lung adenocarcinoma cells. The Journal of Biological Chemistry, 296, 100319.
  • Zang, L., et al., 2023. Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer. Aging,), 15 (23), 14109–14140.
  • Zeng, Y., et al., 2022. AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer. Journal of Clinical Laboratory Analysis., 36 (6), e24437.
  • Zhang, C., et al., 2020. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics, 10 (15), 6561–6580.
  • Zhang, D. L., et al., 2018. Genome-wide identification of transcription factors that are critical to non-small cell lung cancer. Cancer Letters, 434, 132–143.
  • Zou, D., et al., 2022. AFF2 is associated with X-Linked partial (focal) epilepsy with antecedent febrile seizures. Frontiers in Molecular Neuroscience, 15, 795840.